many diseases including cancer. 3 Indeed, several studies found lower plasma levels of carotenoids, vitamin E, and vitamin C in patients suffering from existing cancers than in matched controls, 4 and, more important, in prospective studies lower plasma levels can predict subsequent cancers. 5 But any rank order of antioxidants is debatable, and it is even unclear whether plant constituents other than the antioxidants mentioned above participate in health protection. Unfortunately, the mechanisms by which these antioxidant vitamins and carotenoids could counteract mutagenesis and carcinogenesis are only poorly understood.
Stomach cancer is among the leading cause of cancer death besides lung, colon, prostate and breast cancer. Inadequate dietary habits are regarded as probably the most important factor in promoting this disease. 6 Casecontrol and prospective studies have clearly shown a link between a high incidence of stomach cancer and a low intake of vegetables and fruits. [7] [8] [9] Corresponding results have been obtained using plasma levels of β-carotene contained in high amounts in vegetables and fruits, instead of intake data. 4, 10 Recently, interest has focused also on other carotenoids. 11 In this paper the model of Poisson regression with e-i-v is for the first time applied to an epidemiological study. We use Japanese populations (ref.11) as the data source. Among the parameters measured (vitamin A, vitamin C, vitamin E, β-carotene, lutein and lycopene), plasma lycopene is the best explanatory variable for stomach cancer (ICD-9: 151). The results of these calculations are summarized as relative risks of age and lycopene levels.
STUDY DESIGN
The study design is described in detail elsewhere. 11 Briefly, blood samples were obtained from randomly chosen apparently healthy men (40-49 years old, with a response rate Ͼ70%) during the period January through April in each study site ( Table 1) . The sample sizes varied between n = 114 and n = 131. The plasma was analysed for vitamins, carotenoids, and polyunsaturated fatty acids (PUFA) in a central laboratory with rigid quality control.
For each centre, the annual deaths according to ICD-9 were reported separately for four age groups (41-45, 46-50, 51-55, 56-60 years) during a different number of subsequent years (Table 1) . Census data for corresponding time periods were also provided ( Table 1) . As the time periods of observations vary from population to population we performed a summation of the number of deaths over the periods yielding the total number of deaths in the respective population and age group. Summation of the census number over the same periods yields the corresponding population at risk (Table 1) .
MODEL DESCRIPTION
The Poisson distribution is adequate to describe the occurrences of a very small number of deaths in a given population. In this study, the following variables are entered into the Poisson regression model: the number of deaths of the population at risk and its size in four age groups. As the lycopene status of the fatal cases is not known we substitute it by the median of the corresponding sample and use it as a covariate. We choose the median instead of the mean for its robustness with respect to outliers. The true population median of lycopene is unknown but can be estimated by the sample median. The standard error of the median is estimated by bootstrapping methods. 12 Thus, two aspects of lycopene variation are considered; the variation within the sample and the deviation of the sample median from the unknown true median of the census population. The model allows for overdispersion (variance exceeding the nominal value given by the parameter of the Poisson distribution) occurring due to unknown effects which are not included in the model; this can be simulated by an additional random effect term. 13 One could classify this model as 'Error in Variables Poisson Regression with Overdispersion'-a model which is very elegantly treatable in a Bayesian framework using Monte Carlo techniques.
If we denote by n ij the number of deaths in population i and age group j (j = 
The logarithm of the expectation E ij of the underlying Poisson distribution was analysed by the following model:
log(E ij ) = log(N ij ) + µ + α j + β*Lt i + λ ij (equation 1) where:
N ij is the number of persons at risk in population i and age group j. µ is a term for the overall mean. α j Coefficient of the effect of age group (j = 1-3). As we allow for an overall mean, we choose arbitrarily a parametrisation with the fourth age group as reference group. β Regression parameter for lycopene. Lt i (Unknown) value of the true median of lycopene in population i. There is no index for age group as in many samples the ages of the volunteers are only known in a wider range. λ ij Random error term due to overdispersion.
Furthermore, the following relations are used in order to define the model: Figure 1 shows the representation of this model as a directed graph.
14 The nodes are either constants (rectangles) or stochastic variables (circles), which may be data or parameters.
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FIGURE 1 Graphical model for the error in variable model
The nodes are either constants (rectangles) or stochastic nodes (circles), which may be data or parameters. Li of the sampling error of the medians was obtained by bootstrapping. 12 Diffuse but proper normal priors (mean 0, variance 10 4 ) were used on the parameters µ (grand mean), α j (age group), β (lycopene median), the random error terms λ ij and the unknown true lycopene medians Lt i . A diffuse (mean 1, variance 10) gamma prior distribution was chosen for σ λ 2 .
As starting values, points near the estimators of a classical GLIM model without e-i-v were taken. After a burn-in of 1000 iterations, a huge sample (10 000 cycles) was drawn and checked for stability and convergence (e.g. by choosing different initial starting points for the sampling procedure). After checking for convergence, the resampling statistics, including the 95% confidence interval (CI) for the parameters in the model were computed.
In order to compare our model with a linear regression model, we compared its total deviance 13 with the square root of the residual variance of the corresponding linear model. In this model, the mortality is expressed as cases/100 000 and the same as the right hand side of equation 1. Furthermore, we defined a 'generalized R 2 ' as
where d i is the deviance residual of the i-th observation and d i0 the deviance residual in the model with only a 'grand mean'. In the case of a linear model (normally distributed), the generalized-R 2 becomes the usual R 2 . Figure 2 shows the decadic logarithm of the death rates for each age group versus the population medians of plasma lycopene. In cases where there were no deaths in a specific age group we set the log mortality rate to -4.5 for the graphical representation.
RESULTS
Since the model was treated in a Bayesian context, the results are posterior densities for all occurring parameters. The posterior densities are reported by their means, medians and upper as well as lower limits of the 95% CI ( Table 2) . The Poisson regression model has been calculated with and without e-i-v.
The relative risk indicated in the last column of Table 2 is defined as exp(ξ), where ξ stands for the respective model parameter and its posterior distribution was obtained within the same resampling steps. In the case of age group j, j = 1-3, it can be interpreted as the relative risk compared with the oldest group (56-60 years), when all other variables are held constant. As it had been expected, the risk monotonically increases with increasing age group. The relative risk estimation based on the regression parameter β denotes the decrease of risk by comparing the maximum (0.22 µmol/l) and the minimum (0.06 µmol/l) of the population medians of lycopene. The median of the relative risk calculated is then 0.46 (95% CI : 0.23-0.79).
Because the 95% CI of the parameters α j (j = 1, 2, 3) and β do not include 0, a decrease of the corresponding risk is highly probable.
The posterior distribution of the variance of the additional variability (σ 2 λ ) indicates an only small amount of overdispersion which means that only few variability is not explained by the model.
The resampled posterior distributions of the generalized R 2 (defined in 'model fitting') of the Poisson regression with e-i-v and of the linear regression model (with e-i-v) are summarized in Table 3 . It is evident from the smaller SD and the narrower 95% CI that the Poisson regression leads to a more precise estimation of the distribution.
We compared the Poisson regression with inclusion of e-i-v with the corresponding model without this additional error term. The effect of the inclusion of e-i-v is very small. This is not a surprise since the sample median must be very close to the unknown true population median due to the actual sample sizes of about 120 in the populations. In order to demonstrate the effect of e-i-v more clearly, we took a random subsample of 20 observations from each population sample. The bootstrapped standard deviations of the medians of plasma lycopene are then much greater. Including e-i-v in the model leads to similar estimates of the parameter β as using the full sample (Table 4) . For comparability reasons, all calculations were again performed by Gibbs sampling with the program BUGS.
Usually, non-consideration of e-i-v leads to an attenuation of the corresponding regression coefficient. In our case, the e-i-v term slightly separates the lycopene medians for each age group within a population, which leads to the opposite effect (Table 4 ; mean of the posterior distribution of β in case of the subsample -6.43 versus -5.37). However, the SD of the posterior distribution is smaller adding e-i-v into the model (2.39 versus 2.11 in the subsample).
DISCUSSION
We propose a useful model for analysing mortality data from a multi-centre epidemiological study. The observed mortality can be considered to follow a Poisson distribution. The variable lycopene (plasma status of the corresponding population) can only be estimated by means of a randomly chosen sample. The unknown individual value of the fatal cases is substituted by the population median. The true lycopene median, measured by the population median, is only known within the sampling error. The variance of the sampling error was estimated by a bootstrap algorithm. Bayesian statistics offers a theoretically elegant way of stating models, but its practical application had been limited by computational intractability. Now, the Gibbs sampler is the tool which enables us to implement also very complicated models in many fields and has been successfully applied in a wide range of statistical applications such as pharmacokinetics 18 and image reconstruction. 19 A further advantage of the Bayesian statistics is that one avoids the problem of multiple testing.
With the help of a Poisson regression model the results become easily interpretable because one can calculate a relative risk. In addition, the residual error is smaller which results in a higher generalized R 2 (0.78) compared to the R 2 of 0.71 of the corresponding linear regression model with the same predictor (including e-i-v).
In spite of the rather small size of the effect, we suggest that such models should be implemented for further modelling where other covariates may be considered as well and where possible interfering parameters are accounted for-nevertheless we found a surprisingly small amount of overdispersion in our data. The obvious advantages of correcting for e-i-v are: (i) more accurate estimate of the coefficient, (ii) reduced overdispersion, (iii) increased precision of the regression coefficient (smaller SD of its posterior distribution).
It is obvious (i) and (ii) become much more eminent in the case of small samples. The lack of inclusion of e-i-v leads in our example not to a attenuation of the estimate for β: In our specific case, the e-i-v term separates the lycopene medians for each age group within a population which leads to a 'pulling apart' of the independent variable. Furthermore, with e-i-v the estimation of β based on the subsample is very close to the estimation of the original sample whereas without inclusion of e-i-v the difference is much larger. This implies that a consideration of e-i-v effects may help to reduce sample sizes without a great loss of accuracy in the estimators.
Generally, the small overdispersion also indicates that the model adequately describes the data and may be used for similar problems. 
